By Dave Sebastian 



  CVS Health Corp. raised its full-year guidance as it posted higher profit for the second quarter, partly benefiting from deferred elective procedures related to its insurance business amid Covid-19 shelter-in-place measures. 


  The pharmacy chain now expects earnings of $5.59 a share to $5.72 a share, or $7.14 a share to $7.27 a share on an adjusted basis. It previously expected earnings of $5.47 a share to $5.60 a share, or $7.04 a share to $7.17 a share on an adjusted basis. 


  It expects cash flow from operations of $11 billion to $11.5 billion for the year, up from $10.5 billion to $11 billion it had previously guided for. 


  CVS said it projects higher use in its health-care benefits segment for the rest of the year. 


  Write to Dave Sebastian at dave.sebastian@wsj.com